Sehhoon Park

机构：Samsung (South Korea), Samsung Medical Center, Sungkyunkwan University · ORCID：0000-0001-9467-461X

发表论文 158 篇 · 总被引 2126 次 · h-index 24

代表论文

• Artificial intelligence-powered spatial analysis of tumor microenvironment in patients with non-small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitor (2025 · Journal for ImmunoTherapy of Cancer · 被引 13)
• Lazertinib for Patients with NSCLC Harboring Uncommon EGFR Mutations: A Phase II Multicenter Trial (2025 · Journal of Thoracic Oncology · 被引 7)
• Combination of chemotherapy and immune checkpoint inhibitors in non-small cell lung cancer with actionable gene alterations other than EGFR, ALK, and ROS1 mutations: a retrospective observational study (2025 · BMC Cancer · 被引 6)
• Deep-Learning Model for Real-Time Prediction of Recurrence in Early-Stage Non–Small Cell Lung Cancer: A Multimodal Approach (RADAR CARE Study) (2025 · JCO Precision Oncology · 被引 2)
• Adjuvant pembrolizumab therapy for completely resected stage I lung adenocarcinoma with micropapillary or solid histological subtypes: a single-center, single-arm, phase 2 trial (2025 · EClinicalMedicine · 被引 2)
• Artificial intelligence-powered spatial analysis of tumor infiltrating lymphocytes and tertiary lymphoid structures in non-small cell lung cancer patients treated with immune-checkpoint inhibitors±chemotherapy. (2025 · Journal of Clinical Oncology · 被引 1)